| A Trial of SHR-1139 in Healthy Volunteers (NCT07078695) | Atridia Pty Ltd. | 2025-08-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants (NCT07136103) | AbbVie | 2025-08-19 |
| RE104 Radiolabeled Mass Balance (hAME) Study (NCT07146191) | Reunion Neuroscience Inc | 2025-08-19 |
| A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults (NCT07059403) | Chimivac INC | 2025-08-19 |
| Dexamethasone-Enhanced TAP Block in Lapchole (NCT07182110) | Makassed General Hospital | 2025-08-19 |
| Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients (NCT07210047) | HuniLife Biotechnology, Inc. | 2025-08-18 |
| Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection (NCT07149454) | Lanzhou Institute of Biological Products Co., Ltd | 2025-08-18 |
| Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373) (NCT07154901) | AstraZeneca | 2025-08-18 |
| A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors (NCT07123103) | Exelixis | 2025-08-18 |
| A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors (NCT07085091) | ALX Oncology Inc. | 2025-08-18 |
| Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia (NCT07120607) | Anhui Provincial Hospital | 2025-08-18 |
| A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease (NCT07011771) | Capsida Biotherapeutics, Inc. | 2025-08-18 |
| A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis (NCT06906900) | M.D. Anderson Cancer Center | 2025-08-18 |
| A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function (NCT07137689) | Eli Lilly and Company | 2025-08-18 |
| Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers (NCT07158346) | Celltrion | 2025-08-18 |
| A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer (NCT07026279) | Amplia Therapeutics Limited | 2025-08-18 |
| A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039) (NCT07121959) | Merck Sharp & Dohme LLC | 2025-08-18 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers (NCT06995482) | Kashiv BioSciences, LLC | 2025-08-18 |
| A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis. (NCT07081646) | Alexion Pharmaceuticals, Inc. | 2025-08-18 |
| Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants (NCT07182656) | Yi Fang | 2025-08-18 |
| A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women (NCT07118085) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2025-08-18 |
| To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT (NCT07280494) | Peking University People's Hospital | 2025-08-18 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension (NCT06585163) | Quivive Pharma, Inc. | 2025-08-18 |
| To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL (NCT07143929) | Peking University People's Hospital | 2025-08-18 |
| A Phase 1 Study of JADE101 in Healthy Participants (NCT07059312) | Jade Biosciences, Inc. | 2025-08-17 |
| HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata (NCT07049328) | HCW Biologics | 2025-08-16 |
| A Study of SKB107 in Advanced Solid Tumors With Bone Metastases (NCT07087197) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2025-08-15 |
| Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2) (NCT06943495) | Jean-Mathieu Beauregard | 2025-08-15 |
| Periprostatic Neurolysis in Prostate Cancer (NCT07100847) | University of Texas Southwestern Medical Center | 2025-08-15 |
| Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis (NCT07093268) | Brain Trust Bio | 2025-08-15 |
| Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes (NCT06484062) | National Cancer Institute (NCI) | 2025-08-15 |
| Comparison Study of Insulin GZR4 With Insulin Degludec (NCT07146347) | Gan and Lee Pharmaceuticals, USA | 2025-08-15 |
| Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer (NCT06931626) | Nerviano Medical Sciences | 2025-08-15 |
| Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation (NCT07158710) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-15 |
| A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants (NCT06397144) | Pfizer | 2025-08-15 |
| A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers (NCT07088822) | Medigen, Inc. | 2025-08-15 |
| A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes (NCT06938334) | Altheia Science | 2025-08-15 |
| Clinical Evaluation of Montelukast in Veterans With Gulf War Illness (NCT05992311) | Baylor College of Medicine | 2025-08-15 |
| Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer (NCT07139470) | Tianjin Medical University Cancer Institute and Hospital | 2025-08-15 |
| Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial (NCT06866262) | University of Michigan Rogel Cancer Center | 2025-08-15 |
| Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers (NCT07708623) | Materia Medica Holding | 2025-08-15 |
| QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) (NCT07131085) | Anhui Provincial Hospital | 2025-08-15 |
| Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma (NCT07730515) | Evopoint Biosciences Inc. | 2025-08-15 |
| FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis (NCT06690710) | Scarcell Therapeutics S.A.S. | 2025-08-14 |
| Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis (NCT07146971) | Good Molecules, LLC | 2025-08-14 |
| Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET (NCT05385861) | National Health Research Institutes, Taiwan | 2025-08-14 |
| A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer (NCT07777211) | Beijing Gene Key Life Technology Co., Ltd | 2025-08-14 |
| A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants (NCT07130097) | Pfizer | 2025-08-14 |
| A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL) (NCT07137494) | Memorial Sloan Kettering Cancer Center | 2025-08-14 |
| Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation (NCT06735664) | City of Hope Medical Center | 2025-08-14 |
| Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation (NCT06966388) | Virginia Commonwealth University | 2025-08-13 |
| IN10018 Combination Therapy in Previously-treated Solid Tumors (NCT05982522) | InxMed (Shanghai) Co., Ltd. | 2025-08-13 |
| A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases (NCT07123519) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-08-13 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults (NCT06994897) | Pfizer | 2025-08-13 |
| A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL) (NCT07082868) | Memorial Sloan Kettering Cancer Center | 2025-08-13 |
| Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants (NCT07083817) | Qpex Biopharma, Inc. | 2025-08-13 |
| A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial) (NCT07136545) | Taipei Veterans General Hospital, Taiwan | 2025-08-13 |
| A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC) (NCT06959537) | M.D. Anderson Cancer Center | 2025-08-13 |
| Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (NCT07160179) | AbbVie | 2025-08-13 |
| A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014) (NCT07063238) | Merck Sharp & Dohme LLC | 2025-08-12 |
| A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age (NCT07105722) | GlaxoSmithKline | 2025-08-12 |
| Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function (NCT07144098) | Gan & Lee Pharmaceuticals. | 2025-08-12 |
| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors (NCT07070232) | BioNTech SE | 2025-08-12 |
| A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder (NCT07001475) | Boehringer Ingelheim | 2025-08-12 |
| Phase 1 Study of ADX-626 in Healthy Participants (NCT07081503) | ADARx Pharmaceuticals, Inc. | 2025-08-12 |
| PRoMiSS: Psilocybin and the Role of Music in Set and Setting (NCT07180108) | Johns Hopkins University | 2025-08-12 |
| Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV (NCT07055451) | Gilead Sciences | 2025-08-12 |
| Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial. (NCT07208240) | Rabin Medical Center | 2025-08-12 |
| A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers (NCT07162441) | Korea United Pharm. Inc. | 2025-08-12 |
| A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. (NCT07042100) | Sun Pharma Advanced Research Company Limited | 2025-08-12 |
| Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies (NCT06700811) | Heather Olson | 2025-08-11 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZKLJ02 Injection in Healthy Chinese Research Participants (NCT07638098) | Yunnan Zhongke Longjin Biotechnology Co.,Ltd. | 2025-08-11 |
| A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes (NCT07032688) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-11 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects (NCT07166081) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-08-11 |
| A Study of HDM2020 in Patients With Advanced Solid Tumors (NCT07098052) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-08-11 |
| A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin. (NCT07121153) | Novo Nordisk A/S | 2025-08-11 |
| A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs (NCT06908928) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2025-08-11 |
| E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers (NCT05639972) | Christian Hinrichs | 2025-08-11 |
| Study of GS-1219 in Participants With HIV-1 (NCT07115368) | Gilead Sciences | 2025-08-11 |
| Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults (NCT07095231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-08-11 |
| A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD. (NCT07116915) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-08-11 |
| A Study to Learn About a Vaccine Against E Coli in Healthy Adults (NCT07122986) | Pfizer | 2025-08-11 |
| Study of MAR002 in Healthy Men (NCT07195175) | Marea Therapeutics | 2025-08-11 |
| Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors (NCT07122063) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2025-08-11 |
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood (NCT07100964) | Boehringer Ingelheim | 2025-08-11 |
| A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension (NCT06749236) | Vigonvita Life Sciences | 2025-08-11 |
| A Study of LY3985863 in Healthy Participants (NCT07030127) | Eli Lilly and Company | 2025-08-11 |
| Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects (NCT07134465) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-11 |
| A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes (NCT07126873) | EndoCell Therapeutics, Inc. | 2025-08-11 |
| A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors (NCT07105215) | RemeGen Co., Ltd. | 2025-08-11 |
| Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers (NCT07072325) | West China Hospital | 2025-08-10 |
| A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) (NCT07239947) | Bambusa Therapeutics | 2025-08-09 |
| Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial (NCT07397026) | Hagar Ahmed Ali Mohammed Elzain | 2025-08-09 |
| Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight (NCT07110766) | MindRank AI Ltd | 2025-08-09 |
| A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma (NCT07107178) | Biotroy Therapeutics | 2025-08-08 |
| A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL) (NCT07001384) | Memorial Sloan Kettering Cancer Center | 2025-08-08 |
| Accelerated rTMS vs. Sham for Stroke Apathy (NCT07113067) | Medical University of South Carolina | 2025-08-08 |
| Food Effect Study of HSK47388 in Healthy Subjects (NCT07192692) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-08 |
| A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma (NCT07105059) | Memorial Sloan Kettering Cancer Center | 2025-08-08 |
| Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma (NCT06892054) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2025-08-08 |